Alison Worth

947 total citations
6 papers, 674 citations indexed

About

Alison Worth is a scholar working on General Health Professions, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Alison Worth has authored 6 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in General Health Professions, 3 papers in Oncology and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Alison Worth's work include CAR-T cell therapy research (2 papers), Palliative Care and End-of-Life Issues (2 papers) and Interpreting and Communication in Healthcare (1 paper). Alison Worth is often cited by papers focused on CAR-T cell therapy research (2 papers), Palliative Care and End-of-Life Issues (2 papers) and Interpreting and Communication in Healthcare (1 paper). Alison Worth collaborates with scholars based in United Kingdom and United States. Alison Worth's co-authors include Aziz Sheikh, Marilyn Kendall, Debbie Cavers, Anna Lloyd, Scott Murray, Emma Carduff, Liz Grant, Fiona Harris, Scott A Murray and Hilary Pinnock and has published in prestigious journals such as European Journal of Oncology Nursing, BMJ and Regular and Young Investigator Award Abstracts.

In The Last Decade

Alison Worth

6 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alison Worth United Kingdom	5	307	222	124	117	106	6	674
Eva Sahlberg‐Blom Sweden	17	330 1.1×	227 1.0×	65 0.5×	121 1.0×	54 0.5×	26	673
Cathy Shipman United Kingdom	14	466 1.5×	270 1.2×	51 0.4×	119 1.0×	95 0.9×	20	678
Ken Sellick Australia	14	256 0.8×	160 0.7×	85 0.7×	192 1.6×	60 0.6×	27	859
Donna Waters Australia	21	235 0.8×	405 1.8×	386 3.1×	169 1.4×	102 1.0×	63	1.3k
Mette Spliid Ludvigsen Denmark	13	198 0.6×	215 1.0×	42 0.3×	216 1.8×	55 0.5×	54	773
Vera Radünz Brazil	11	240 0.8×	201 0.9×	46 0.4×	236 2.0×	42 0.4×	80	659
Anne Brødsgaard Denmark	13	141 0.5×	131 0.6×	110 0.9×	286 2.4×	90 0.8×	68	582
Gabriel T. Bosslet United States	14	517 1.7×	430 1.9×	98 0.8×	167 1.4×	51 0.5×	46	1.0k
Clayton J. Shuman United States	14	175 0.6×	225 1.0×	35 0.3×	126 1.1×	35 0.3×	47	541
Kirsten Auret Australia	20	653 2.1×	421 1.9×	90 0.7×	232 2.0×	62 0.6×	61	1.2k

Countries citing papers authored by Alison Worth

Since Specialization

Citations

This map shows the geographic impact of Alison Worth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Worth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Worth more than expected).

Fields of papers citing papers by Alison Worth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Worth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Worth. The network helps show where Alison Worth may publish in the future.

Co-authorship network of co-authors of Alison Worth

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Worth. A scholar is included among the top collaborators of Alison Worth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Worth. Alison Worth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Gabbasov, Rashid, Alison Worth, Michael Ball, et al.. (2022). 371 Chimeric antigen receptor macrophages (CAR-M) sensitize solid tumors to anti-PD1 immunotherapy. Regular and Young Investigator Award Abstracts. A390–A390. 4 indexed citations

2.

Anderson, Nicholas R., Michael Klichinsky, Stefano Pierini, et al.. (2022). 194 Pre-clinical development of CT-1119, a mesothelin targeting chimeric antigen receptor macrophage (CAR-M), for solid tumor immunotherapy. Regular and Young Investigator Award Abstracts. A207–A207. 3 indexed citations

3.

Taylor, Anne, Mary Wells, Gill Hubbard, & Alison Worth. (2016). From an illusion of certainty into a reality of uncertainty: A longitudinal qualitative study of how people affected by laryngeal cancer use information over time. European Journal of Oncology Nursing. 23. 15–23. 10 indexed citations

4.

Pinnock, Hilary, Marilyn Kendall, Scott A Murray, et al.. (2011). Living and dying with severe chronic obstructive pulmonary disease: multi-perspective longitudinal qualitative study. BMJ. 342(jan24 1). d142–d142. 265 indexed citations

5.

Kendall, Marilyn, Scott Murray, Emma Carduff, et al.. (2009). Use of multiperspective qualitative interviews to understand patients' and carers' beliefs, experiences, and needs. BMJ. 339(oct14 3). b4122–b4122. 160 indexed citations

6.

Murray, Scott, Marilyn Kendall, Emma Carduff, et al.. (2009). Use of serial qualitative interviews to understand patients' evolving experiences and needs. BMJ. 339(sep28 1). b3702–b3702. 232 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact